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Abstract
Progesterone is an anti-inflammatory and promyelinating agent after spinal cord injury, but its effectiveness on functional
recovery is still controversial. In the current study, we tested the effects of chronic progesterone administration on tissue
preservation and functional recovery in a clinically relevant model of spinal cord lesion (thoracic contusion). Using magnetic
resonance imaging, we observed that progesterone reduced both volume and rostrocaudal extension of the lesion at 60 days
post-injury. In addition, progesterone increased the number of total mature oligodendrocytes, myelin basic protein immu-
noreactivity, and the number of axonal profiles at the epicenter of the lesion. Further, progesterone treatment significantly
improved motor outcome as assessed using the Basso-Bresnahan-Beattie scale for locomotion and CatWalk gait analysis.
These data suggest that progesterone could be considered a promising therapeutical candidate for spinal cord injury.
Key words: CatWalk; oligodendrocytes; progesterone; spare white matter; spinal cord injury
Introduction
After spinal cord injury (sci), primary mechanical insult isfollowed by the activation of a secondary cascade of events
that ultimately causes progressive degeneration of the neural tissue.
These secondary events include vascular abnormalities, ischemia-
reperfusion, glutamate excitotoxicity, neuronal and oligodendro-
cyte death, oxidative cell injury, glial reactivity, axonal loss, and a
robust inflammatory response.1–3
Effective treatments should ideally act on part or all of those events
to finally spare tissue and preserve axonal tracts, oligodendrocytes,
and myelin sheaths. No gold standard therapy for SCI has been es-
tablished,4–6 although clinical trials with methylprednisolone (NAS-
CIS II and III) have demonstrated modest therapeutic benefits.7,8
Progesterone (PROG) could represent a good candidate for
therapy, because it is neuroprotective, promyelinating, and anti-
inflammatory in pathologies of peripheral and central nervous
systems.9–12
Specifically, in experimental brain trauma, PROG reduces ede-
ma and inflammatory cytokines, prevents neuronal loss and mito-
chondrial dysfunction, and improves functional outcomes.13–15
This has permitted the development of two Phase II clinical trials
that have recently shown significant improvements in patients with
traumatic brain injury receiving PROG.16–18
In our previous studies, we demonstrated beneficial effects of
PROG after complete section of spinal cord: it restores the expres-
sion levels of several molecular markers, subsides chromatolysis in
motoneurons,19,20 enhances the differentiation of oligodendrocyte
precursor cells by increasing the expression of pro-oligodendrogenic
factors such as Olig2 and Nkx2.2,21 and decreases the activation and
proliferation of astrocytes and microglial cells.22
In this study, we have assessed histological and functional effect
of PROG with multiple approaches, including magnetic resonance
imaging (MRI), stereological cell counting, open field based Basso-
Bresnahan-Beattie (BBB) scale for locomotion, CatWalk gait anal-
ysis, Hargreaves plantar test, and dynamic Von Frey.
Our investigation provided compelling evidence that PROG
significantly improved tissue preservation and functional outcome
after spinal cord contusion. These results showed that PROG could
be considered a strong candidate for the therapy of SCI, beause it
has been considered for traumatic brain injury.
Methods
Animals
Young adult male Wistar rats (300–335 g, 12 weeks old) ob-
tained from Harlan-interfauna Ibe´rica (Barcelona, Spain) were
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maintained in a 12:12 h light:dark cycle, and received food and
water ad libitum. Rats were handled in accordance with the
guidelines published in the National Institutes of Health (NIH)
Guide for the Care and Use of Laboratory Animals, the principles
laid out in the Guidelines for the Use of Animals in Neuroscience
Research published by the Society for Neuroscience, and European
Union guidelines (Council Directive 86/609/EEC). Experimental
procedures were approved by the Ethical Committee for Animal
Welfare at the National Paraplegics Hospital (CEBA). Special care
was taken to use the minimum number of animals needed for sta-
tistical accuracy.
SCI
Male Wistar rats were submitted to a moderate-severe contusive
spinal cord injury as described previously.23,24 Briefly, animals
were anesthetized with an intraperitoneal injection of sodium
pentobarbital (45mg/kg, Normon Veterinary Division, Madrid,
Spain) and Xilagesic (2% xylazine, 10mg/kg, Calier, Barcelona,
Spain). Once the absence of reflexes had been checked, the rats
were injected with a low dose of atropine (50lg/kg body weight;
BrownMedical, Barcelona, Spain) to reduce salivary and bronchial
secretions and to avoid the induction of bradycardia and possible
cardiac arrest by the surgery or xylazine. Artificial tears were ap-
plied to the eyes to prevent corneal abrasion and infection.
We performed a laminectomy of T8 vertebra, and the vertebral
column was stabilized by clamping spiny processes of T7 and T9
vertebrae. Spinal cord contusion was performed with the Infinite
Horizon device (Precision Systems and Instrumentation, Lex-
ington, KY), applying a force of 200 Kdyn without any additional
dwell time.25 Force and displacement curves generated by the In-
finite Horizon were checked to confirm that injuries were per-
formed with similar intensities and profiles, showing no artifacts
indicative of an erroneous/abnormal lesion, therefore ensuring con-
sistency and reproducibility of the injury. This method enabled us to
reduce the number of lesioned animals to a minimum, avoiding
animal suffering without compromising the statistical accuracy. The
injury produced by this method is equivalent to that described as
moderate-severe by other groups.26,27 Sham operated animals re-
ceived the same protocol of laminectomy but without contusion.
Postoperative care included a subcutaneous injection of Buprex
(buprenorphine, 0.05mg/kg; Schering Plough, Madrid, Spain) and
a prophylactic subcutaneous antibiotic injection 1 h after the lesion
and on the following day (Baytril, Enrofloxacine, 1mg/kg; Bayer,
Kiel, Germany). The animals were fed with wet extruded rodent
food, and manual bladder expression was used until they were self-
voiding (within 10 days). The animals were monitored for hydra-
tion and eventual infections until the end of the experiment.
PROG treatment
Injured animals received daily subcutaneous injections of natural
PROG (16mg/kg/day, Sigma Aldrich, n= 8, SCI+PROG group) or
vehicle (castor oil, SigmaAldrich, n= 8, SCI group) for 60 days until
sacrifice. PROG was given to awake animals 1 h after injury. This
dose of PROG has been shown to prevent edema and neuronal loss
and to improve cognitive responses after brain-contusion injury,28 to
induce oligodendrogenesis and remyelination after spinal cord in-
jury,21,29 and to decrease reactive gliosis.22 Sham-operated rats
(n= 8, CTL) received a laminectomy but not SCI.
Magnetic resonance data acquisition and analysis
Rats were anesthetized and transcardially perfused with 4%
paraformaldehyde in 0.1M phosphate buffer 60 days after injury.
The spinal cord was dissected out and post-fixed for 4 h in the same
solution at 4C. Spinal cords were placed in Fluorinert (Sigma,
Madrid, Spain), and MRI was performed on a 4.7-T Bruker
BioSpec system (Bruker, Karlsruhe, Germany) with a H1 surface
coil. Three dimensional T2-weighted Fast Spin Echo images
(T2W-3D) were acquired with the following parameters: repetition
time (TR) 1650 msec, echo time (TE) 70 msec, number of averages
(NA) = 1, slice thickness 0.5mm, 16 sagittal slices per sample, field
of view (FOV) 2.56 · 1.28 · 0.8 cm2, and data matrix 256·
128 · 16. T2W-3D hyperintense lesions in the spinal cord were
identified and the volumes and lengths were measured with Image
J software (NIH, Bethesda, MD).23,30
Tissue processing for immunohistochemistry
and Luxol Fast Blue (LFB) staining
After MRI studies, spinal cords were immersed in a solution of
30% sucrose in 0.1M phosphate buffer during 72 h at 4C. Tissue
blocks of 5mm including the epicenter of the spinal cord lesion in
the middle of the block were then embedded in optimum cutting
temperature compound (Tissue-Tek, Sakura Finetek, Zoeterwoude,
NL), frozen on dry ice, cut into 50-mm thick serial coronal sections
on a cryostat, and sequentially collected on slides. After immuno-
histochemistry and LFB staining, cross-sections were examined
under a light microscope, at 40 · or 60 · magnification, equipped
with a digital camera PanasonicGPKR2 22 connected to anOlympus
BH2 microscope. Image analysis was performed using Bioscan
Optimas II software or Image J, NIH image analysis software. All
slides were assessed blindly with respect to treatment.
LFB staining
Sections were treated with 95% ethanol and left in LFB solution
(0.1mg% LFB in 95% ethanol with 10% acetic acid) at 60C for
18 h. After several washes, sections were immersed in lithium
carbonate and then 70% ethanol, rinsed in distilled water, dried, and
mounted with Permount.
Immunohistochemistry
Immunostaining was performed as described previously21 using
primary antibodies against myelin basic protein (MBP 1:100,
Abcam, Cambridge, UK), neurofilament H (NF-H 1:1000, Abcam,
Cambridge, UK), or adenomatus polyposis coli (APC) clone (clone
CC1 1:100, Calbiochem, Darmstadt, Germany), and secondary
biotinylated anti-rabbit immunoglobulin G (IgG) (1/200 Vector
Laboratories, Burlingame, CA) or biotinylated anti-mouse IgG (1/
200 Vector Laboratories). After the incubation with secondary
antibodies, sections were incubated with avidin-biotin complex
(ABC) for 30min (ABC kit, Vector Laboratories) and finally re-
vealed with diaminobenzidine tetrachloride (0.50mg/mL, Sigma,
St. Louis, MO) in the presence of 0.01%H2O2 for 7min in the dark.
The sections were given a final rinse in phosphate buffered saline,
dehydrated in graded ethanols and xylene, and mounted with Per-
mount. CTL experiments were performed to rule out interference of
non-specific staining. These experiments were run in parallel and
involved the incubation of tissue without primary antibodies.
Quantification of tissue sparing
Serial sections were taken every 0.5mm from 2.5 rostral up to
2.5mm caudal to the epicenter and were assayed for LFB staining.
The spared area of white and gray matter in each section was
quantified using NIH image analysis software Image J. The white
matter was determined to be spared if LFB staining was grossly
normal in appearance and density (lacking cysts and degeneration)
and spared gray matter estimation was based on comparison with
normal gray matter cytoarchitecture observed in naı¨ve animals.25,31
We calculated the volume of spared white matter (SWM) and
spared gray matter (SGM) by multiplication the spared area of each
section by section thickness. The volume of spared tissue was
normalized as a percentage of the volume of white and gray matter
measured at the same spinal levels in intact rats.
858 GARCIA-OVEJERO ET AL.
Optical density measurement of MBP
Optical density of MBP staining was measured as described
previously.21 Briefly, inmmunostaining intensity was determined
in areas (50,000 lm2) covering three white matter regions: dorsal
funiculus, lateral funiculus, and ventral funiculus, anatomically
delimited by themethod described in Labombarda and associates.21
Computer-assisted image analysis (Bioscan Optimas II) was used
to transform differences in color intensity of immunopositive areas
into gray differences, and results were expressed as the mean –
standard error of the mean inverse logarithm of gray intensity per
unit area (mm2) (ILIGV/area =LIGV).20 Sections were processed
simultaneously under identical light beam, wavelength, and gray-
scale threshold throughout the experiment and quantification
analysis. LIGV was averaged for each section and expressed as a
percentage of CTL intact animals.
Stereological APC (CC1) counting
Serial sections were taken every 0.5mm from 2.5 rostral up to
2.5mm caudal to the epicenter and were assayed for APC im-
munostaining. The number of total APC + cells was estimated using
the optical dissector method with total section thickness as the
dissector height and a counting frame of 60mm· 50mm.32 Section
thickness was estimated using the fluorescent properties of hema-
toxylin, so counterstained sections were examined under a Nikon
Eclipse E 800 confocal scanning laser microscope. A total of 240
counting frames (24 per section covering dorsal, lateral, and ventral
white matter funiculus) were assessed per animal. Knowing the
volume of the dissector in each section, we calculated the number
of APC+ cells/mm3. To obtain the total number of APC+ cells, we
multiplied the number of cells/mm3 per the total volume of spinal
cord (the summation of cross-sectional areas · thickness section
· distance between slices).
Quantification of axonal profiles
We obtained micrographs of ventral, dorsal, and lateral white
matter with a bright fieldmicroscope using a 60· objective. The final
area of the picture was 25,000mm2, with a final pixel size of 0.239
microns· 0.179 microns. We performed a semi-automated quanti-
fication of axonal profiles using NIH image analysis software Image
J. Pictures were transformed in 8-bit grayscale images, then con-
verted to binary images using manual threshold. Dilate, Watershed
and Erode filters were applied to the images, and finally the auto-
mated counting tool included in Image J was used. To obtain total
axonal profile in white matter, we multiplied axonal profile density
(axonal profile/mm2) per white matter area of dorsal, ventral, and
lateral funiculus. Finally, the number of axonal profiles per funiculus
was added, and axonal preservation was expressed as percentage of
total axonal profile in white matter with respect to CTL animals.
Open-field locomotion
Open-field locomotion was evaluated by using the BBB loco-
motor scale according to the instructions published in the original
articles.26,27 Briefly, animals were gently placed to the open field
during several sessions. Then, two trained observers (blind to
hormone treatment) scored rats for 4min at the same time of the day
at 3, 7, 14, 30, and 60 days after SCI. One researcher recorded all
the data on a score sheet, and the other one kept the animal moving
in the open field. Movements elicited by the touch of an examiner
were not scored. A score of 0 points defines no movement of the
hindlimbs (HL), and the maximum of 21 points defines normal
locomotion as observed in unlesioned rats. Score includes criteria
such as joint movements, weight support, forelimb-hindlimb (FL-
HL) coordination, and tail position.
Because interlimb coordination can be quite difficult to assess in
the open field, we corrected open field BBB scoring using an ob-
jective assessments of coordination with the CatWalk system
(CatWalk-based BBB score) according to Koopmans and col-
leagues.33 We acquired and studied five uninterrupted runs with the
CatWalk system on the day of open field testing, considering
‘‘consistent coordination’’ when Regularity Index (RI) (Table 1)
scored 100% in 5/5 runs; ‘‘frequent coordination’’ when RI scored
100% in 3/5 or 4/5 runs; ‘‘occasional coordination’’ when RI scored
100% in 1/5 or 2/5, and ‘‘no coordination’’ when RI scored 100% in
0/5 runs. We also used the BBB subscoring scale to improved the
sensitivity of the BBB by scoring the higher motor functions (i.e.,
toe clearance, predominant paw position, trunk stability, and tail
position) regardless of the other BBB parameters, adding them
together to yield a single score (maximum score = 13).34
CatWalk-automated quantitative gait analysis
While the general locomotor performance was evaluated us-
ing the BBB scale, a more detailed analysis of locomotion was
performed using the CatWalk gait analysis system in rats that
were able to maintain weight support with their HL (BBB score
above 9). CatWalk measures a large number of both static and
dynamic gait parameters and enables quantitative assessment of
locomotion.33,35–39
Briefly, the CatWalk system consists of a glass runway that
contains light from a fluorescent tube. Internal reflection causes the
light to be restricted to the glass surface plate under normal cir-
cumstances.When an object touches the glass surface, however, the
light exits the glass, thereby only illuminating the contact area.
Hence, placement of the rat paws on the glass floor lights up the
corresponding areas on the glass floor. The run of the animal across
the glass runway is detected by a video camera (Pulnix TM 765E,
Pulnix Inc., U.K.) positioned underneath the glass plate. The signal
is digitized (50 frames/sec) by a Picolo Diligent frame grabber
board. The data are acquired, compressed, stored, and eventually
analyzed by the CatWalk 7.1 software program.35
One week before the surgery, animals were trained to walk
across the CatWalk, baseline scores were recorded, and rats were
then tested on days 14, 30, and 60 post-surgery (when animals
regained at least frequent weight supported stepping). For loco-
motor analysis, the following criteria concerning walkway crossing
had to be met: (1) the rat crossed the walkway without any inter-
ruption or hesitation with a consistent pace, (2) a minimum of five
correct crossings with about four step cycles (i.e., each paws po-
sitioned four times) were acquired and analyzed per animal, and (3)
to avoid a high variability in gait velocities, only runs with a stable
crossing time of the runway between 3 and 4 sec were included.
Because no left-right differences were present in any of the gait
parameters investigated, corresponding left and right gait param-
eters were averaged before analysis. The analyzed parameters are
described in Table 1. For a full description of the locomotor pa-
rameters, see Hamers and coworkers.36
Sensory function
Sixty days after injury, rats were brought into the behavior room
1 h before the test session to allow them to habituate to the envi-
ronment. Animals were placed alone in each behavioral apparatus
for 15min before testing, and trials of a particular sensory test were
separated by at least 1 hr. They received sugared cereal rewards
throughout testing to keep them from attending to the movements
and procedures of the examiner. The average value of three read-
ings was used as the tolerance threshold for each hindpaw.
Mechanical sensitivity. The sensitivity to touch stimuli was
assessed by using the dynamic plantar aesthesiometer (Ugo Basile,
Varese, Italy), an automated apparatus based on the Von Frey fil-
ament principle. Rats were placed in a raised cage with a wire mesh
floor over the stimulator unit. The metal filament was applied to the
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center of the palmar surface of the hindpaw, and upward force was
increased from 1 to 50 g over 15 sec. Force at withdrawal was
recorded for both hindpaws.40,41
Thermal sensitivity. The Plantar test (Ugo Basile, Varese,
Italy) was used to evaluate thermal hyperalgesia according to the
Hargreaves method.42 Rats were placed in a cage with a glass
floor, over a movable infrared light source. The light source was
positioned under the center of the palmar hindpaw, and it was
turned off automatically when the rat lifted the paw, allowing the
measurement of time between the beginning of the light beam and
the elevation of the foot. To prevent tissue damage, a 20-sec cutoff
time was set. Thermal withdrawal latency was recorded for both
hindpaws.40,41
Statistical analysis
All the statistical analysis and graphs were performed with Prism
5.0 software (www.graphpad.com/support). All the data are pre-
sented as means – standard errors. For BBB and BBB subscoring
analysis, the nonparametric Mann-WhitneyU test was used. A two-
way analysis of variance of repeated measures followed by the
Bonferroni post-test was used to determine statistical differences
between treatments in the different rostrocaudal regions from the
epicenter or at different time points after injury
One-way analysis of variance followed by the Newman Keuls
post-test or t test was used to determine statistical differences be-
tween three or two treatments, respectively, at 60 days. The number
of rats was used as the n number (n = 8 for all treatments). A p < 0.05
was considered to be significant.
Results
SCI
The real force at the impact site and the mean amount of spinal
cord displacement, two key parameters in defining the severity of
injury, did not show significant differences between SCI and
SCI + PROG groups, ensuring consistency and reproducibility of
the injury (force: SCI 204.3– 1.42 Kdyn vs. SCI+ PROG
204.9 – 1.66 Kydn; displacement: SCI 1188– 53.47mm vs. SCI +
PROG 1212 – 33.56mm). After surgery, animals showed an initial
drop in body weight during the first postoperative days, increasing
afterward until the end of the study. There were no differences
between the groups (data not shown).
PROG reduced secondary damage and increased
spared tissue
We determined the effect of PROG on the extension of the lesion
60 days after injury by quantifying ex vivo the edema-related hy-
perintense signaling in T2W-3D MRI, which mainly reflected the
cyst already formed.43–45 PROG reduced volume and length of T2
hyperintense signals when compared with SCI rats (Fig. 1A, B, C).
In addition, the non-hyperintense region and the total volume of
Table 1. CatWalk Parameters Analyzed
Explanation
Base-of-support (BOS) Distance between the two hindpaws, as measured perpendicular to the walking direction.
Stride length Distance between the placement of a paw and the subsequent placement of the same paw.
Print area The total surface area of the complete print.
Max area Maximum area of a paw that comes into contact with the glass plate; it is the print area at maximum contact.
Paw angle Estimate of the angle (in degrees) of the paw axis relative to the horizontal plane.
Print intensity The mean brightness of all pixels of the print at Max contact. Intensity ranges from 0 to 255. The intensity
of a signal depends on the degree of contact between a paw and the glass plate and increases with
increasing pressure. Therefore, intensity is an indirect measure of weight support of the different paws.
Stance duration Time of contact of the hindpaw with the glass floor.
Swing duration Time that the hindpaw is not in contact with the glass floor.
Duty cycle Expresses stance duration as a percentage of the duration of the step cycle. It is calculated as follows:
Duty cycle: stand/stand + swing * 100 %.
Regularity index (RI) An index for the degree of interlimb coordination during gait, as measured by the number of normal step
sequence patterns (NSSP), multiplied by four (number of paws), divided by the number of paw placements,
and multiplied by 100%; RI = (NSSP · 4)/number of paw placements · 100%, With respect to RI, six NSSP
have been described previously36 and involve cruciate, alternate, and rotary step patterns. In healthy (fully
coordinated) animals, its value is 100%; loss of interlimb coordination obviously leads to a decrease in this
parameter.
Phase dispersions (PD) Measure for interlimb coordination based on time-relationships between footfalls. The moment of initial
contact of one paw (the Target) is related (expressed as a percentage) to the stride cycle of another paw (the
Anchor). PD can be calculated between limbs on the same grindle (forepaws or hindpaws - grindle pair),
between limbs on the same side (ipsilateral left or ipsilateral right - lateral pair) and between diagonal paws
(opposite front/hindpaws - diagonal pair). Within diagonal pairs (RF-LH, LF-RH) and ipsilateral pairs (RF-
RH, LF-LH), the Anchor is always one of the front paws. Within girdle pairs (LF-RF, LH-RH), the Anchor
paw is always one of the left paws.
Phase dispersions
variability
The standard deviation of the mean of PD values for each pair of paws. Coordinated locomotor activity
is characterized by minor PD variability during uninterrupted locomotion. It is a measure
of accurancy in the inter-limb coordination
RF, right forelimb; RH, right hindlimb; LF, left forelimb; LH, left hindlimb.
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spinal cord at the epicenter region were significantly increased in
PROG +SCI rats 60 days after the injury (Fig. 1D, E).
Next, we studied the effect of PROG administration on the ex-
tension of the lesion and tissue sparing at the histological level. We
performed LFB staining on serial coronal sections taken between
2.5mm rostrally and 2.5mm caudally from the epicenter, and we
quantified SWM and SGM (Fig. 2).
After 60 days, injured animals lost approximately 77% of white
matter in segments located 2.5mm rostral and caudal to the epi-
center, while PROG treatment reduced white matter decrease to
about 42% (i.e., 2.5mm rostral: SCI: 22.99– 3.03%; SCI +PROG:
58.60 – 4.06, p< 0.001, Fig .2A). The amount of white matter
preservation at the epicenter itself was approximately 7% in SCI
rats, while in SCI +PROG animals, it was about 16% (SCI:
7.29 – 1.74%; SCI +PROG: 16.19– 2.17%, p < 0.05, Fig. 2A). The
preservation of SWM was observed between SCI and SCI +PROG
groups at all distances measured from the epicenter (Fig. 2A).
On the other hand, no statistical differences were observed be-
tween the SCI and SCI+ PROG rats in SGM (SCI vs. SCI + PROG,
p> 0.05, Fig. 2B).
Additional quantitative assessment of the area of white matter at
lateral and ventral funiculus was performed at the epicenter itself,
because this parameter is related to supraspinal control.46,47 This
area was significantly larger in contusioned animals treated with
PROG than in the vehicle group (Fig. 2C, SCI+PROG: 0.38mm2–
0.034 vs. SCI: 0.27mm2– 0.067, p< 0.05).
FIG. 1. Representative T2-weighted three-dimensional magnetic resonance imaging (T2W-3D MRI) showing smaller hyperintense
region in spinal cord injury plus progesterone (SCI + PROG) rats (A). Effects of PROG treatment on reducing lesion extension (B),
cyst formation (C), preservation of non-hyperintense tissue (D), and total spinal cord volume (E) at the epicenter region after 60 days
of injury. All values are expressed as mean – standard error of the mean, *p < 0.05 vs. SCI, **p < 0.01 vs. SCI, ***p < 0.001 vs. SCI,
t test.
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PROG administration increased oligodendrocyte
numbers and reduced myelin damage after SCI
We studied the effect of PROG administration on oligoden-
drocyte preservation. We stereologically quantified the number
of CC1 + cells in SWM within a 5mm segment of the lesion
epicenter.
After 60 days of spinal cord contusion, lesioned animals showed
a 93.46% reduction in the total number of CC1 + cells throughout
the white matter, while PROG-treated rats showed a higher number
of cells, losing about 65% of oligodendrocytes compared with
sham-operated rats (CTL: 425 103 – 13.18 103, SCI: 27.83
103 – 4.30 103, SCI + PROG: 127.4 103 – 13.18 103; p< 0.001 SCI
vs. CTL; p < 0.001 SCI vs. SCI + PROG; Fig. 3A, B).
Next, we measured MBP immunoreactivity in the SWM of
2.5mm rostral, 2.5mm caudal, and the midpoint of the epicenter
region (Fig. 3C). MBP immunoreactivity diminished dramati-
cally in SCI rats at all studied regions but was partially preserved in
SCI animals treated with PROG (SCI vs. SCI+ PROG, p< 0.01 at
all regions, Fig. 3C). Therefore, increased oligodendrocyte den-
sity in the PROG-treated group was accompanied by better myelin
preservation.
PROG improved axonal preservation
after spinal cord contusion
We also evaluated the number of axonal profiles on sections
immunostained against NF-H. Quantification revealed a higher
axonal preservation in PROG-treated animals compared with
vehicle-treated ones (SCI + PROG vs. SCI, p < 0.05 or less at all
regions, Fig. 4A, B). This axonal protection was verified along
the whole 5-mm segment.
PROG improved locomotor outcome after SCI
Open-field locomotion. The general locomotor performance
was evaluated using the BBB scale, but interlimb coordination was
corrected with the RI value obtained in the CatWalk gait analysis
(CW-BBB) (see Methods, Table 1).
All rats manifested significant bilateral HL paralysis immedi-
ately after injury. After 14 days, SCI rats improved their scores,
showing consistent weight-supported HL steps but no FL-HL co-
ordination (CW-BBB score = 11), while PROG-treated rats dem-
onstrated consistent coordinated FL-HL movements (CW-BBB
score = 14) ( p < 0.05 SCI vs. SCI +PROG, Fig. 5A). This pattern
FIG. 2. Effect of progesterone (PROG) on white and grey matter damage measured at 60 days after lesion. An increase in spred white
matter (SWM) preservation was observed in spinal cord injury (SCI) +PROG rats at all distances measured from the epicenter (A).
PROG did not modify the volume of spared grey matter (SGM) along the segment (B). Micrographs showing coronal section of spinal
cord stained with Luxol Fast Blue from the epicenter region. Spinal cord contusion produced a cavitation at the epicenter, leaving a
greater sparse region of intact white matter in the ventral-lateral margins (lateral and ventral funiculus) in SCI + PROG group (C). All
values are expressed as mean – standard error of the mean. For A and B: ***p < 0.001 vs. SCI, **p < 0.01 vs. SCI, *p< 0.05 vs. SCI, two-
way analysis of variance of repeated measures followed by Bonferroni post-test. For C: scale bar = 200 lm.
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was maintained for the duration of the assessment period. Beha-
vioral improvements seen in PROG-treated animals were present at
each time point after 14 days ( p< 0.05 at all time points, Fig 5A).
As indicated in Methods, the BBB subscore evaluates aspects of
fine motor control regardless of the other BBB parameters.34,48
After 14 days, the BBB subscore of SCI animals became stable at a
score of 2, whereas PROG-treated animals eventually reached a
higher score between 5 and 8 (Fig. 5B). At 60 days post-injury,
PROG rats presented better subscores than the SCI group: 75% of
PROG rats had the tail consistently up, 50% had consistent trunk
stability and parallel paw position of HL during the stance, and 62%
showed consistent toe clearance. In the SCI group, only 37% of rats
had the tail up, none of the rats reached trunk stability and parallel
paw position, and 12% showed consistent toe clearance.
CatWalk-automated quantitative gait analysis
Fourteen days post-injury, all rats in both groups reached a BBB
score higher than 9, allowing us to test their locomotor performance
also by CatWalk gait analysis. Importantly, gait velocity, which
strongly affects the variations in gait parameters, is controlled using
the Cat-Walk36 by training the animals to make runs with a stable
crossing time. During this study, no significant differences were
found between animal groups with respect to crossing time or aver-
age bodyweight, another parameter that affects gait (data not shown).
There were no significant differences in any studied parameter for the
functions of the FL between SCI and SCI+PROG rats.
Base of support (BOS) of the hindpaws. The distance
between the hindpaws during locomotion is an indicator of trunk
stability of the animal. BOS was higher in SCI rats throughout the
test period compared with sham control animals ( p < 0.001 at all
time points, SCI vs. CTL, Fig. 6A). PROG-treated rats showed a
decrease in BOS with respect to SCI rats ( p< 0.05 or less at all time
points, SCI vs. SCI +PROG, Fig. 6A). During the study, BOS in-
creased slightly over time in all groups, probably because of the
normal increases in body weight (CTL, SCI, SCI + PROG; Time: F
(2, 42) = 5.24, p< 0.05, Fig. 6A).
Stride length. Stride length decreased significantly in injured
rats compared with sham-operated animals ( p< 0.05 or less at all
time points, SCI vs. CTL, Fig. 6B). PROG-treated rats, however,
showed an increased stride length compared with SCI rats
( p< 0.05, SCI vs. SCI + PROG, Fig. 6B) and remained closer to
sham-operated values (ns, SCI +PROG vs. CTL, Fig. 6B)
FIG. 3. Progesterone (PROG) increased the oligodendrocytes number and reduced myelin damage 60 days after lesion. Spinal cord
injury (SCI) animals showed a reduction in the total number of CC1 + cells throughout the white matter compared with control (CTL)
rats, while the in SCI +PROG group, the reduction was lower (A). Micrographs showing CC1 immunohistochemistry in ventrolateral
white matter at the epicenter region in the different groups of animals (B). Myelin basic protein (MBP) immunoreactivity increased in
SCI + PROG rats compared with SCI rats at 2.5mm rostral, 2.5mm caudal, and the midpoint - 0mm- from the epicenter (C). All values
are expressed as mean– standard error of the mean. For A: ***p< 0.001 vs. CTL, +++ p< 0.001 vs. SCI, one-way analysis of variance
(ANOVA) followed by Newman Keuls post-test. For C: ***p< 0.001 vs. CTL, ++ p< 0.01 vs. SCI, +++ p< 0.001 vs. SCI, two-way
ANOVA of repeated measures followed by Bonferroni post-test. For B: scale bar = 20 lm.
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Duty cycle, Stance, and Swing. The Duty cycle is the per-
cent of the total step cycle during which a paw is on the ground
(Table 1). The Duty cycle of the hindpaws increased in injured rats
( p < 0.05 or less at all points, SCI and SCI + PROG vs. CTL, Fig.
6C), but this increase was smaller in rats treated with PROG
( p < 0.05 or less at all time points, SCI vs. SCI + PROG, Fig. 6C).
The time that the hindpaw was not in contact with the glass floor
(Swing phase) decreased in all injured animals, but to a lesser
extent in PROG-treated animals throughout the study ( p< 0.05 at
all time points SCI vs. SCI +PROG, Fig. 6E). The time that the
hindpaws were in contact with the floor (Stance phase), however,
was significantly increased in both groups of lesioned animals
only after 14 and 30 days ( p < 0.05 SCI and SCI + PROG vs. CTL,
Fig. 6D).
Print area, Max area, and Paw angle. Even though the du-
ration of the Stance phase did not change among groups, we evaluated
additional characteristics of the Stance by studying Print area, Max
area, and Paw angle (see Table 1). After 14 and 30 days, both injured
groups showed statistically significant increases in Print area andMax
area comparedwith sham, but without significant differences between
them (data not shown). After 60 days, however, the Max Area and
Print area values remained similar in SCI rats while in SCI+PROG
animals, both parameters decreased, reaching values similar to those
of sham-operated rats (Table 2). Paw angle increased throughout the
study in injured animals, but to a lesser extent in those treated with
PROG (data not shown). Data at 60 days are shown in Table 2.
RI. This parameter reflects FL-HL coordination, correlating
the order of paw placements of the animal with the normal step
sequence patterns.35,36 In sham-operated animals, all runs reached a
RI of 100%, showing perfect interlimb coordination. In injured
animals, mean RI was reduced in both groups from 2 weeks after
injury ( p< 0.05 vs. CTL, Fig. 7), but the decrease was smaller in
PROG-treated animals at all time points ( p < 0.05 SCI vs. SCI +
PROG, Fig. 7). These PROG-treated animals recovered interlimb
coordination reaching RI values similar to control rats at 30 days
(95.72 – 1.64, ns SCI+ PROG vs. CTL) and 60 days (96.76 – 1.19,
ns SCI +PROG vs. CTL, Fig. 7).
Phase dispersions (PD). Another parameter used to esti-
mate coordination is the measurement of PD, which, in contrast
to the RI, determine the paw placements with respect to timing
(Table 1). Changes in PD variability represent a measure of in-
terlimb coordination: during uninterrupted locomotion, coordi-
nated limb pairs show very small phase dispersion variability,
whereas limbs that move largely autonomously display a high
variability.33,49
We averaged the values of complementary pairs to perform
statistical analysis: PD diagonal pairs is the average between left
forward-right hindlimb (LF-RH) and right forward-left hindlimb
(RF-LH) and PD ipsilateral pairs is the average between right
forward-right hindlimb (RF-RH) and left forward-left hindlimb
(LF-LH). We also estimated the PD variability of pectoral (LF-RF)
and pelvic (LH-RH) girdles.
FIG. 4. Progesterone (PROG) improved axonal preservation 60 days after injury at 2.5mm rostral, 2.5mm caudal, and at the
midpoint - 0mm- of the epicenter (A). Micrographs show neurofilament (NF-H) immohistochemistry in ventrolateral white matter at the
epicenter region in the different groups of animals. Spinal cord injury (SCI) group showed less axonal profiles than control (CTL), while
in SCI + PROG rats, the number was recovered (B upper panel). Examples of processed images used for quantification are shown (B
lower panel). All values are expressed as mean– standard error of the mean. For A: ***p < 0.001 vs. CTL, +++ p < 0.001 vs. SCI, two-
way analysis of variance of repeated measures followed by Bonferroni post-test. For B: scale bar = 20 lm.
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Injury severely increased PD variability in all pairs of paws
compared with sham animals (ipsilateral pairs: F2,42= 42.26,
p < 0.001, Fig. 7B; diagonal pairs: F2,42= 38.27, p < 0.001, Fig. 7C;
pelvic girdle: F2,42= 31.37, p< 0.001, Fig. 7D). Significant effects
of PROG treatment became apparent after 14 days, however. The
PD variability was significantly lower in SCI + PROG than in SCI
rats in the ipsilateral and diagonal pairs and in the pelvic girdle
( p < 0.05 SCI vs. SCI +PROG Fig. 7B, C, D). The value of PD
variability was stable inside each group over time, not existing
statistically significant differences from 14 onward (ipsilateral
pairs: F2,42= 2.43, ns, Fig. 7B; diagonal pairs: F2,42 = 1.02, ns,
Fig. 7C, pelvic girdle: F2,42= 3.50, ns, Fig. 7D).
On the other hand, changes in PD mean value represent changes
in the step patterns during gait.49 Lesioned animals showed changes
in the mean PD for ipsilateral and diagonal pairs vs sham-operated
controls, but no difference was observed between SCI and SCI +
PROG rats (data not shown)
Sensory function
Animals were tested for mechanical and thermal sensitivity
to explore sensory functions after 60 days of spinal cord
contusion.
Mechanical sensitivity. There was no significant difference
in the filament force necessary to elicit a hindpaw withdrawal be-
tween the SCI rats and sham-operated animals, indicating no sig-
nificant mechanical allodynia in our model of contusion (Fig. 8A).
In addition, chronic PROG administration did not change the
threshold of response to mechanical stimulation (Fig. 8A). This was
supported also by the absence of differences in some CatWalk
parameters such as the duration of Stance phase (Fig. 6D) and the
pressure applied during Stance (Print intensity) and by the increase
in the area contacted by the paw during the stand (Print area) and
the increase of the area contacted at the moment of maximum paw-
floor contact (Max area) (Table 2). Decreases in those parameters
have been previously related to mechanical allodynia.50,51
Thermal sensitivity. As for mechanical stimulation, no sta-
tistically significant differences were observed between groups,
showing that our model did not produce thermal hyperalgesia and
that PROG administration did not induce changes in the nocicep-
tive behavior (Fig. 8B).
Discussion
The current study demonstrated that PROG treatment after spinal
cord contusion was beneficial at the anatomical, histological, and
functional levels. Because at present there are no universally ac-
cepted treatments for this neurological disorder, our present inves-
tigation identifies PROG as a promising candidate for clinical trials.
PROG reduced secondary injury
and white matter pathology
By MRI techniques, we observed that the volume of hyperin-
tense signal was smaller in rats treated with PROG, suggesting that
the steroid effectively reduced edema formation after spinal trau-
ma. This is in agreement with previous reports showing that PROG
reduces edema formation after traumatic brain injury16 by de-
creasing the expression of aquaporin-4 at the zone of injury52 and
by stabilizing the blood–brain barrier with its antioxidant effects.53
The improvement in tissue preservation and total spinal cord vol-
ume may imply a secondary damage reduction, an effect expected
given the already described effects of PROG in decreasing in-
flammation and reactive gliosis13,22,54,55 reducing oxidative
stress53 and decreasing excitotoxicity via indirect conversion into
allopregnenalone.9,56–58
Further, PROG notably reduced the extension of the hyperin-
tense signal in a rostrocaudal direction. This would imply that
PROG may be beneficial for injuries located near the lumbar or
cervical enlargements, where limiting the expansion of the primary
damage would preserve levels containing, for example, central
pattern generators for locomotion or breathing control.
Our histological measurements support and extend our MRI
findings: SWM values were higher at all distances measured in
PROG-treated rats in accordance with the MRI data. A remarkable
agreement across studies indicates that only 5–10% tissue sparing
is necessary for the recovery of plantar stepping (BBB score =
10–11).27,59–61 Accordingly, SWM was about 7% at the epicenter
of lesioned rats that showed a consistent stepping (mean BBB
score= 11) 60 days after the lesion. Interestingly, PROG treatment
preserved 16% of SWM at the epicenter, and rats demonstrated
consistent plantar stepping with FL-HL coordination (mean BBB
score= 14). This confirms that a small increase in SWMmay result
in a substantial recovery of locomotor function, probably by pre-
serving more supraspinal and propiospinal inputs.27,49,61
FIG. 5. Integration of the CatWalk(CW)-based coordination
into the Basso-Bresnahan-Beattie (BBB) locomotor scale results
in the CatWalk-based BBB, which showed that spinal cord injury
plus progesterone (SCI+ PROG) animals regained better loco-
motor function when compared with SCI rats (A). BBB subscore
also showed marked differences between SCI and SCI + PROG
rats (B). All values are expressed as mean – standard error of the
mean, *p< 0.05 vs. SCI, **p < 0.01 vs. SCI, ***p< 0.001 vs. SCI,
nonparametric Mann-Whitney U test.
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In this regard, after PROG treatment, the areas of dorsolateral
and ventrolateral funiculus were significantly larger at the epicenter
site. White matter tracts that occupy the outer rim of the cord such
as the rubro-, raphe-, reticulo- and vestibulospinal tracts are part of
the descending brainstem system that appear to provide important,
if not essential, input to the central pattern generator (CPG) to
initiate locomotion and produce complex and precise locomotor
patterns.46,47,62 Thus, axon sparing of these tracts by PROG treat-
ment may underline the described locomotor recovery.
PROG and its reduced metabolite, allopregnenalone, are well
recognized promyelinating factors in the peripheral and central
nervous systems in several diseases.9–12,63–67 We have demonstrated
in previous works that chronic PROG administration increases the
expression of transcription factors that define oligodendrocyte lin-
age, such as Olig2 and Nkx2.2 after spinal cord transection.21,29 In
the present work, we report that PROG treatment reduced the loss of
oligodendrocyte numbers and MBP immunoreactivity produced by
SCI. This effect could be because of preservation of the myelin-
producing cells, but also to an increase in oligodendrocyte numbers
by differentiation of oligodendrocyte precursors into mature myeli-
nating oligodendrocytes, promoting the remyelination process. Ei-
ther way, the effects on oligodendrocyte number could contribute to
FIG. 6. CatWalk gait parameters analysis showed that progesterone (PROG) improved overground locomotion. Base of support (A),
Stride length (B), Duty cycle (C), Stand phase (D), and Swing phase (E). All values are expressed as mean – standard error of the
mean, *p < 0.05 vs. contgrol (CTL), **p < 0.01 vs. CTL, ***p< 0.001 vs. CTL, + p< 0.05 vs. spinal cord injury (SCI), + + p < 0.01 vs.
SCI, two-way analysis of variance of repeated measures followed by Bonferroni post-test.
Table 2. Max Area, Print Area and Print Intensity after 60 days of Spinal Cord Injury
Treatments Max area (mm2) Print area (mm2) Paw angle (degrees) Print intensity (a.u)
CTL 42.35– 2.38 56.94– 3.86 5,26 – 1.17 84.79– 2.96
SCI 67.35– 4.33** 110.80– 8.83*** 12.57 – 3.00* 88.22– 2.67
SCI + PROG 51.27– 5.57 # 85.27– 8.87 # 4.73 – 0.87# 81.90– 4.32
CTL, control; SCI, spinal cord injury; PROG, progesterone.
*p< 0.05 vs. CTL; ***p < 0.001 vs. CTL; # p< 0.05 vs. SCI. One-way analysis of and Student Newman Keuls post-test.
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the reported PROG actions in locomotor outcome, because ther-
apeutical strategies that limit white matter damage and oligoden-
drocyte death have been shown to improve recovery after SCI,68,69
and spontaneous functional recovery correlates well with mature
oligodendrocyte number in white matter after spinal cord contu-
sion.70 PROG could have acted directly on oligodendrocytes, or
indirectly by modulating the inflammatory environment, because
PROG treatment decreases gliosis and cytokine production after
spinal cord transection22 (author unpublished results). Further stud-
ies should be performed to answer this question.
We completed the evaluation of SWM with the study of axonal
profile preservation at the epicenter. Quantification revealed a
higher axonal preservation in PROG-treated animals along the
whole 5-mm segment compared with SCI rats. PROG could protect
axons by reducing inflammation, oxidative stress, reactive gliosis,
edema, and excitotoxicity, but also preserving the integrity of the
myelin sheath.71–73 Otherwise, PROG could have promoted axonal
regeneration of supraspinal or propiospinal neurons.
Finally, PROG produced no significant changes in SGM. This is
in accordance with previous reports, which described that func-
tional deficits after midthoracic injuries are mainly attributed to
white matter damage.74–76
PROG improved locomotor outcome
after spinal cord injury
Behavioral recovery is the highest goal in the search for thera-
peutically relevant repair strategies for SCI. An important aspect of
the observed locomotor outcome is the recovery of coordination.
As it was demonstrated by others,27,35,49,77 rats after thoracic spinal
cord trauma exhibited no interlimb coordination (CW-BBB
score= 11, high PD variability of ipsilateral and diagonal pairs of
HL). The group treated with PROG, however, regained better
FIG. 7. PROG treatment improved interlimb coordination after injury. Spinal cord contusion decreased RI in SCI rats compared to
CTL animals, but in a lesser extent in SCI +PROG (A). PD variability was increased in SCI rats compared to CTL in all the studied pairs
of paw. However, in SCI +PROG rats, PD variability was lower compared to SCI in diagonal pair (B), ipsilateral pair (C) a pelvic girdle
(D). All values are expressed as mean– SEM, ***p< 0.001 vs CTL, +p< 0.05 vs SCI. A two-way ANOVA of repeated measures
followed by Bonferroni post-text.
FIG. 8. Neither PROG nor spinal cord injury induced mechanical
or thermal allodynia after 60 days of spinal cord contusion. Dy-
namic Von Frey (A). Plantar test (B). All values are expressed as
mean –SEM and no statistical differences were found by two-way
ANOVA. RH, right hindlimb; LH, left hindlimb.
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locomotor function presenting consistent FL-HL coordination
(CW-BBB score ‡ 14, and values close to control animals in cou-
pling between FL-HL, RI, and PD variability of the ipsilateral and
diagonal pairs). It is generally accepted that coordinated gait can
only be generated when there is a functional connection between
the CPGs of the individual limbs located in the lumbar and cervical
spinal cord.78–81
The recovery of FL-HL coordination in the PROG-treated rats
indicated that communication between FL and HL CPGs has im-
proved. Possible mechanisms underlying the recovery may be: (1)
the preservation of descending brainstem systems, which are im-
portant in activation of CPG (rubro-, vestibulo-, reticuloraphe- and
propiospinal tracts)46,47,62,78; (2) the formation of new intraspinal
circuits that might contact long propiospinal neurons bridging the
lesion and arborizing on lumbar neurons46,82; (3) neuroprotection
and CPG plasticity. In this regard, we have published that PROG
increases the synthesis of BDNF after spinal cord transection,19
which, in turn, like IGF-1, may induce synaptogenesis and CPG
plasticity.33,83 Additional tract-tracing experiments to verify theses
hypothesis would be needed, however.
The greater trunk stability in PROG-treated rats could produce
the improvement of the following gait parameters: BOS, Swing
phase, Print- and Max area, and Stride length. Particularly, an in-
creased BOS is a common feature of SCI36,84,85 and has been ex-
plained as an adaptation for an instable gait.35 Thus, recovery of a
normal hindlimb BOS, 60 days post-injury in PROG-treated rats,
could be related to improvements in trunk stability. These data
agrees with the BBB subscore, which indicated that in SCI + PROG
group, 50% of the rats showed trunk stability, while none of the
rats showed trunk stability in the SCI group. Alternatively, pro-
nounced external hindpaw rotation might increase BOS measure-
ments.36 In this regard, PROG also decreased the hindpaw rotation
after injury, possibly reducing also the BOS. Indeed, the BBB-
subscore showed that 50% of the animals in the SCI + PROG group
reached a normal parallel paw position, while none of the rats
reached the appropriate position in the SCI group.
In accordance with previous reports, Duty cycle increased after
SCI,35,84 because of the reduction of the Swing phase. Conversely,
after PROG treatment Duty cycle almost reached control values,
because Swing phase was increased. That means that the rat paw
falls to the ground faster in vehicle-treated rats than in PROG-
treated rats. Even though the duration of the Stance phase did
not change among groups, we evaluated additional characteristics
of the Stance by studying Print and Max areas. Both parameters
increased after SCI as reported.35 In PROG-receiving rats, how-
ever, Print and Max areas reached values similar to those of sham-
operated rats. The decreasing of the Print area, as suggested by
Hamers and coworkers,36 may be because of the consistent toe
clearence that showed in 50% of the SCI + PROG rats.
Stride length normally decreases after injury36,38,86; however,
PROG treatment raised this parameter, and rats tended to recover
the ability to step a normal distance. These results might be the
consequence of an improvement in BOS, the increase of Swing
phase, and greater trunk stability.
Treatments that produce beneficial effects after SCI also may
present undesired effects. In our current study, we checked whether
PROG effects on locomotion were accompanied by the development
of mechanical allodynia or thermal hyperalgesia. In the spinal con-
tusion model, it has been described that normal sensory function is
supported by as little as 10% of white matter sparing.49 Accordingly,
we did not find mechanical allodynia or thermal hyperalgesia in
rats with SCI, and we assessed that PROG did not induce such
behaviors either, neither measured by classical tests, such as hot and
cold plate and the Hargreaves method, nor with CatWalk param-
eters normally decreased in animals in which allodynia is developing
(Stance, Print Intensity, Print and Max area).50,51
Data obtained in the present study demonstrate that PROG im-
proved locomotor outcome after thoracic contusion. There is no
general consensus about the functional effects of PROG after SCI,
however. While improvement of motor and histological outcome
has been reported in one study,87 no recovery is observed in an-
other.88 The discrepancies between our present investigation and
the report by Fee and colleagues88 may be mainly because of the
duration of PROG treatment. They performed an acute treatment of
5 days, while we treated the rats with PROG during all the exper-
iment (60 days), suggesting that a long-term treatment is needed to
observe the behavior outcome.
Conclusion
The current study adds further evidence to support PROG as a
potential effective treatment after SCI, as it has been used for
traumatic brain injury.
We suggest that beneficial actions of PROG on locomotor out-
come could be related to the reduction of secondary damage and the
preservation or regeneration of axons and myelin of the descending
pathways, and with the increase of oligodendrocytes number, either
by inhibiting their apoptosis or promoting their differentiation.
Most of the clinical trials for SCI are directed to limiting secondary
injury to prevent neurological function loss and to provide the
anatomical substrate for further reparation.89 In this line of evi-
dence, PROG treatment holds promise for success. In fact, multi-
potential drugs such as PROG, which have pleiotrophic sites of
action and modulate multiple injury mechanisms, could be the
focus of future clinical trials in spinal cord trauma.
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